Affordable Access

Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs.

Authors
  • Corrao, Giovanni1
  • Zambon, Antonella
  • Faini, Silvia
  • Bagnardi, Vincenzo
  • Leoni, Olivia
  • Suissa, Samy
  • 1 Dipartimento di Statistica, Università degli Studi di Milano-Bicocca, Via Bicocca degli Arcimboldi, 8, Edificio U7, 20126 Milan, Italy. [email protected]
Type
Published Article
Journal
Journal of Clinical Epidemiology
Publisher
Elsevier
Publication Date
January 2005
Volume
58
Issue
1
Pages
92–97
Identifiers
PMID: 15649676
Source
Medline
License
Unknown

Abstract

Evidence that higher doses of short-acting inhaled beta(2)-agonists are associated with higher mortality from COPD was consistently supplied by three observational approaches.

Report this publication

Statistics

Seen <100 times